Injective's native token INJ is holding steady around $4.58, with open interest climbing 5.14% and institutional traders keeping a 59.5% net long position. Technical analysis points to a potential rally to $5.91 within eight weeks, assigning a 65% probability to that move.
What the data shows
Open interest, the total value of outstanding futures contracts, rose by over 5% in the latest session. That kind of uptick often signals fresh money entering the market rather than just existing positions being rolled over. Meanwhile, institutional traders — as measured by exchange flow data and large-holder metrics — are leaning heavily long, with nearly three-fifths of their exposure on the bullish side.
The price itself has been stuck in a narrow band near $4.58 for days, a pattern traders call consolidation. It usually means the market is building a base before making a bigger move, one way or the other.
The technical case for $5.91
Chart analysts point to a series of higher lows and a resistance level that, if broken, could open the path to $5.91. The 65% probability estimate comes from a standard moving-average-plus-volatility model that factors in recent price action and open-interest trends. That target represents roughly a 29% gain from current levels.
No single indicator guarantees a breakout, of course. The same setup could just as easily fail if broader crypto sentiment turns negative or if a large holder decides to cash out.
Why open interest matters here
Rising open interest during a consolidation phase is often viewed as confirmation that traders are adding positions in anticipation of a move. When open interest falls, it suggests liquidation or profit-taking. The current 5.14% increase, combined with the institutional long bias, creates a backdrop where any upward push could accelerate as short sellers get squeezed.
That said, open interest is a lagging indicator — it tells you what already happened, not what happens next. Traders will be watching whether volume picks up above $4.70 or if the price slips below $4.40, either of which could trigger the next leg.
No official statement from Injective Labs or any exchange has been issued regarding the price action. The moves are entirely market-driven.
